Clin2
NCT06529939Possibly a fitNot yet recruiting

Psilocybin and shared film experience study

Disorders of ConsciousnessPsychedelic Experiences

Treatments studied

Part of Brain & nervous system, Mental health clinical trials.

This trial tests how psilocybin affects the way people share and process a film experience. It aims to understand if the drug changes social connection or emotional response.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
30 people
Ages
19 years and older
Study type
Interventional

Who can take part

  • You are 19 years or older
  • You have good general health
  • You have reliable internet access
  • You can read and understand English
  • You are willing to follow the study rules

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06768944Recruiting· Phase 2
Psilocybin and Subjective Experience Study

This study looks at how psilocybin affects people's subjective experience. It aims to understand the mind-altering effects of this psychedelic compound in healthy volunteers.

Calgary, Alberta
NCT07079852Not yet recruiting· Phase 1/Phase 2
Psilocybin and its effects on memory and brain function

This trial tests how psilocybin, a psychedelic substance, affects your thinking, memory, and brain activity. Researchers want to understand these effects in healthy adults who have used psychedelics before.

Austin, Texas
NCT06796361Recruiting· Phase 1
Psilocybin's effect on consciousness: serotonin receptor role

This study tests how psilocybin (the active ingredient in magic mushrooms) affects consciousness by blocking a specific serotonin receptor in the brain. It helps researchers understand why psilocybin causes altered states of mind.

Basel, Canton of Basel-City
NCT06072898Recruiting· Phase 2
Psilocybin brain imaging trial for depression

This study tests whether a single dose of psilocybin (a psychedelic compound) can help treat depression by looking at brain changes on MRI. It is designed for people with moderate-to-severe depression who have not responded well to other treatments.

Toronto, Ontario
NCT06442423Recruiting· Phase 1
Psilocybin study for people with psychiatric symptoms

This trial tests if psilocybin, a substance found in certain mushrooms, can help people with various mental health symptoms that affect daily life. You would take a single dose in a supervised setting and be monitored for changes in your mood and well-being.

New Haven, Connecticut
NCT05301608Recruiting· Phase 1/Phase 2
Psilocybin study of brain activity and changing thoughts

This Phase 1/2 study tests psilocybin to see how it affects brain signals and the “content” of thoughts while you are monitored during the study. Because participants must be generally healthy and mentally stable, it may be an option if you meet those safety and medication rules and are comfortable having your brain activity measured.

Baltimore, Maryland

Hear when a new Psychedelic Experiences trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.